Work

Apremilast for the Treatment of Mild-to-Moderate Hidradenitis Suppurativa in a Prospective, Open-Label, Phase 2 Study

Year: 2019

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: Franz R. Kerdel, Fabio A. Azevedo, Christina Kerdel Don, Frank A. Don, Gabriella Fabbrocini, Francisco A. Kerdel

Language: English

Topic: Hidradenitis Suppurativa and Treatments

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2991165846

FWCI: 5.974

Cites:

Cited by: 37

Related to: 10